Dr David Allsop

BSc(Hons), MRes, PhD
Associate Professor
Psychopharmacology, School of Psychology, Faculty of Science

A16 - Badham Building
The University of Sydney

Telephone +61 2 9351 7665
Fax +61 2 9036 5223

Website The Lambert Initiative for Cannabinoid Therapeutics
Exercise Cannabis Treatment Study
www.davidallsop.net

Biographical details

I gained my Master of Research in Animal Biology at the University of Manchester, UK. I completed my PhD in Evolutionary Biology at the University of Edinburgh, UK. I am currently an Associate Professor in psychopharmacology in the School of Psychology.

Research interests

My broad interests are in psychopharmacology and clnical trials. I am particularly interested in the endocannabinoid system as it relates to health and welbeing and the insights it offers for a biological understanding of diverse disease states. My earlier work focused on understanding cannabis dependence and withdrawal and the development of treatment interventions for cannabis use disorder, including pharmacotherapies such as a Cannabinoid Replacement Therapy - similar in idea to Nicotine Repelacement Therapy. An emerging literature on the many potenital therapeutic targets within the endocannabinoid system has led to a specific interest in the psychopharmacology and clinical applications of cannabinoid therapeutics. Working closely with preclinical and clinical colleagues I am interested in translating basic science into clinical evidence with emphasis on targeting the endocannabinoid system for a diverse range of disease states (epilepsy, cancer, mental health, addictions, metabolic diseases and pain). I am also interested in the development of novel targeted cannabinoid therapeutics, and the regulatory frameworks surrounding clinical work in this space.

Teaching and supervision

Available for teaching: Public health; cannabis and the endocannabinoid system; Drug and Alcohol research; Statistics and experimental design; Research techniques

Current projects

  • 2014-2015 - Does exercise and fasting cause reintoxication in humans? (Associate Investigator) - University of Sydney Bridging Support Grant

  • 2014 - Cannabis use and pain sensitivity: an initial exploration - internally funded

  • 2014 - 2017 – Exercise for cannabis withdrawal – NHMRC Project Grant (CID) - $540,000

  • 2012-2014 – Mental Health Drug and Alcohol Office (MHDAO) Research Grant (CID): Health outcomes associated with long-term cannabis use - $48,400 [complete]

  • 2010 - 2011 Sativex for the management of cannabis withdrawal. NHMRC Project Grant (CIC) - $240,000 [complete]

Associations

College of Problems on Drug Dependence

International Cannabinoid Research Society

Awards and honours

  • 2014 -D Allsop: Internal Research - Non HERDC; McGregor I; University of Sydney/Startup Projects Psychology.
  • 2013 -NIDA International Travel Award - $2100
  • 2011- NIDA International Travel Award - $2100
  • 2004 - 2006 - Conference grants - Royal Commission for the Exhibition of 1851 - $10000
  • 2003 - Winner of Evolution & Ecology Group, Edinburgh University Postgraduate Excellence Prize
  • 2002 - Field research grant - Davis Expedition Fund, Edinburgh University - $1000
  • 2000 - 2004 - Conference grants - Association for the Study of Animal Behaviour - $2000
  • 1998 - Field research grant - Percy Slater Memorial Fund c/o Linnean Society - $1000

In the media

Keywords

Anxiety disorders; Substance abuse and addiction

Selected grants

2016

  • Start-Up activities with or without a pilot and definitive randomised double-blind placebo-controlled trial or oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting; Grimison P, Haber P, Stockler M, Lintzeris N, Simes R, McGregor I, Olver I, Allsop D, Gedye C, Kirby A; NSW Health/Research Project Support.

2015

  • Evaluation of Oromucosal Nabiximols and Vaporised Botanical Leaf Cannabis in Cancer-related Anorexia Cachexia Syndrome: A Pharmacokinetic Study and Phase III Double-blind Randomised Controlled Trial (Cannabis Trial); Naumovski V, Lintzeris N, McGregor I, Allsop D; Health Administration Corporation/Research Support.
  • From ‘BIG DATA’ to evidence: Post-market surveillance of psychotropic medicines in Australia; Schneider C, Pearson S, Karanges E, McGregor I, Buckley N, McLachlan A, Wilson F, Marshall N, Hunt G, Allsop D, Bowen M, Hunt C, Russell J, Abbott M, Lintzeris N; DVC Research/HMR+ Implementation Fund - University.
  • An RCT of cannabinoid replacement therapy (Sativex®) for preventing relapse in treatment-resistant cannabis dependent patients; Lintzeris N, Allsop D, Copeland J, McGregor I, Dunlop A, Shanahan M, Bruno R; National Health and Medical Research Council (NHMRC)/Project Grants.

2014

  • Sativex ratio detection of illicit use for rebuttal; McGregor I, Allsop D; New South Wales Department of Health/Research Support.
  • Randomised control trial of exercise for the management of cannabis withdrawal in adult humans; Lintzeris N, McGregor I, Rooney K, Allsop D, Arnold J; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • Health outcomes associated with long-term cannabis use; Johnston J, Lintzeris N, McGregor I, Allsop D, Bruno R, Phillips C; Health Administration Corporation/Drug and Alcohol Research Grant.

2011

  • A double blind placebo randomised controlled trial of Sativex in the management of cannabis withdraw; Copeland J, Lintzeris N, Allsop D, McGregor I, Norberg M, Dunlop A; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications & creative works

Download citations: PDF RTF Endnote

Journals

  • Allsop, D., Copeland, J. (2016). Age at first cannabis use moderates EEG markers of recovery from cannabis. Journal of Substance Use, 21(4), 400-406. [More Information]
  • Kevin, R., Allsop, D., Lintzeris, N., Dunlop, A., Booth, J., McGregor, I. (2016). Urinary cannabinoid levels during nabiximols (Sativex)-medicated inpatient cannabis withdrawal. Forensic Toxicology, in press. [More Information]
  • Allsop, D. (2015). A potted history of addiction and its treatment in time and space. Metascience, 24, 59-64. [More Information]
  • Allsop, D., Lintzeris, N., Copeland, J., Dunlop, A., McGregor, I. (2015). Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal. Clinical Pharmacology & Therapeutics, 97(6), 571-574. [More Information]
  • Allsop, D., Bartlett, D., Johnston, J., Helliwell, D., Winstock, A., McGregor, I., Lintzeris, N. (2015). The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence. The Journal of Clinical Sleep Medicine, 11(10), 1153-1162. [More Information]
  • Allsop, D., Dunlop, A., Sadler, C., Rivas, G., McGregor, I., Copeland, J. (2014). Changes in cigarette and alcohol use during cannabis abstinence. Drug and Alcohol Dependence, 138, 54-60. [More Information]
  • Copeland, J., Allsop, D. (2014). Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: Client and treatment characteristics and associations with first-time treatment seeking. Drug and Alcohol Review, 33(5), 565-571. [More Information]
  • Wong, A., Keats, K., Rooney, K., Hicks, C., Allsop, D., Arnold, J., McGregor, I. (2014). Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences. Psychopharmacology, 231(20), 3987-3996. [More Information]
  • Johnston, J., Lintzeris, N., Allsop, D., Suraev, A., Booth, J., Carson, D., Helliwell, D., Winstock, A., McGregor, I. (2014). Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology, 231(24), 4623-4636. [More Information]
  • Allsop, D., Copeland, J., Lintzeris, N., Dunlop, A., Montebello, M., Sadler, C., Rivas, G., Holland, R., Muhleisen, P., Norberg, M., Booth, J., McGregor, I. (2014). Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial. JAMA Psychiatry, 71(3), 281-291. [More Information]
  • Molnar, A., Fu, S., Lewis, J., Allsop, D., Copeland, J. (2014). The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC–MS/MS. Forensic Science International, 238, 113-119. [More Information]
  • Allsop, D., Copeland, J., Norberg, M., Fu, S., Molnar, A., Lewis, J., Budney, A. (2012). Quantifying the Clinical Significance of Cannabis Withdrawal. PloS One, 7(9), 1-12. [More Information]
  • Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., Mokri, A. (2012). Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence. Substance Abuse and Rehabilitation, 3(Suppl 1), 37-43.
  • Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., Mokri, A. (2011). Characteristics of Iranian Women Seeking Drug Treatment. Journal of Women's Health, 20(11), 1687-1691. [More Information]
  • Allsop, D., Norberg, M., Copeland, J., Fu, S., Budney, A. (2011). The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence, 119(1-2), 123-129. [More Information]
  • Rooke, S., Thorsteinsson, E., Karpin, A., Copeland, J., Allsop, D. (2010). Computer-delivered interventions for alcohol and tobacco use: A meta-analysis. Addiction, 105(8), 1381-1390. [More Information]
  • Allsop, D., Warner, D., Langkilde, T., Du, W., Shine, R. (2006). Do operational sex ratios influence sex allocation in viviparous lizards with temperature-dependent sex determination? Journal of Evolutionary Biology, 19(4), 1175-1182.
  • Allsop, D. (2006). Industry: policing the 'dark side' of ecology. Nature, 440(7086), 868.
  • Gardner, A., Allsop, D., Charnov, E., West, S. (2005). A dimensionless invariant for relative size at sex change in animals: Explanation and implications. The American Naturalist, 165(5), 551-566.
  • Allsop, D., West, S. (2004). Sex-Ratio Evolution In Sex Changing Animals. Evolution, 58(5), 1019-1027.

Research Reports

  • Arnold, J., Allsop, D., Lintzeris, N., McGregor, I. (2016). Pharmacological actions and associated therapeutic levels of phytocannabinoids : evidence check, Australia: The Sax Institute.

2016

  • Allsop, D., Copeland, J. (2016). Age at first cannabis use moderates EEG markers of recovery from cannabis. Journal of Substance Use, 21(4), 400-406. [More Information]
  • Arnold, J., Allsop, D., Lintzeris, N., McGregor, I. (2016). Pharmacological actions and associated therapeutic levels of phytocannabinoids : evidence check, Australia: The Sax Institute.
  • Kevin, R., Allsop, D., Lintzeris, N., Dunlop, A., Booth, J., McGregor, I. (2016). Urinary cannabinoid levels during nabiximols (Sativex)-medicated inpatient cannabis withdrawal. Forensic Toxicology, in press. [More Information]

2015

  • Allsop, D. (2015). A potted history of addiction and its treatment in time and space. Metascience, 24, 59-64. [More Information]
  • Allsop, D., Lintzeris, N., Copeland, J., Dunlop, A., McGregor, I. (2015). Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal. Clinical Pharmacology & Therapeutics, 97(6), 571-574. [More Information]
  • Allsop, D., Bartlett, D., Johnston, J., Helliwell, D., Winstock, A., McGregor, I., Lintzeris, N. (2015). The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence. The Journal of Clinical Sleep Medicine, 11(10), 1153-1162. [More Information]

2014

  • Allsop, D., Dunlop, A., Sadler, C., Rivas, G., McGregor, I., Copeland, J. (2014). Changes in cigarette and alcohol use during cannabis abstinence. Drug and Alcohol Dependence, 138, 54-60. [More Information]
  • Copeland, J., Allsop, D. (2014). Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: Client and treatment characteristics and associations with first-time treatment seeking. Drug and Alcohol Review, 33(5), 565-571. [More Information]
  • Wong, A., Keats, K., Rooney, K., Hicks, C., Allsop, D., Arnold, J., McGregor, I. (2014). Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences. Psychopharmacology, 231(20), 3987-3996. [More Information]
  • Johnston, J., Lintzeris, N., Allsop, D., Suraev, A., Booth, J., Carson, D., Helliwell, D., Winstock, A., McGregor, I. (2014). Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology, 231(24), 4623-4636. [More Information]
  • Allsop, D., Copeland, J., Lintzeris, N., Dunlop, A., Montebello, M., Sadler, C., Rivas, G., Holland, R., Muhleisen, P., Norberg, M., Booth, J., McGregor, I. (2014). Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial. JAMA Psychiatry, 71(3), 281-291. [More Information]
  • Molnar, A., Fu, S., Lewis, J., Allsop, D., Copeland, J. (2014). The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC–MS/MS. Forensic Science International, 238, 113-119. [More Information]

2012

  • Allsop, D., Copeland, J., Norberg, M., Fu, S., Molnar, A., Lewis, J., Budney, A. (2012). Quantifying the Clinical Significance of Cannabis Withdrawal. PloS One, 7(9), 1-12. [More Information]
  • Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., Mokri, A. (2012). Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence. Substance Abuse and Rehabilitation, 3(Suppl 1), 37-43.

2011

  • Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., Mokri, A. (2011). Characteristics of Iranian Women Seeking Drug Treatment. Journal of Women's Health, 20(11), 1687-1691. [More Information]
  • Allsop, D., Norberg, M., Copeland, J., Fu, S., Budney, A. (2011). The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence, 119(1-2), 123-129. [More Information]

2010

  • Rooke, S., Thorsteinsson, E., Karpin, A., Copeland, J., Allsop, D. (2010). Computer-delivered interventions for alcohol and tobacco use: A meta-analysis. Addiction, 105(8), 1381-1390. [More Information]

2006

  • Allsop, D., Warner, D., Langkilde, T., Du, W., Shine, R. (2006). Do operational sex ratios influence sex allocation in viviparous lizards with temperature-dependent sex determination? Journal of Evolutionary Biology, 19(4), 1175-1182.
  • Allsop, D. (2006). Industry: policing the 'dark side' of ecology. Nature, 440(7086), 868.

2005

  • Gardner, A., Allsop, D., Charnov, E., West, S. (2005). A dimensionless invariant for relative size at sex change in animals: Explanation and implications. The American Naturalist, 165(5), 551-566.

2004

  • Allsop, D., West, S. (2004). Sex-Ratio Evolution In Sex Changing Animals. Evolution, 58(5), 1019-1027.

To update your profile click here. For support on your academic profile contact .